April 2005
Top AIDS researchers to discuss latest advances on vaccine development for HIV-1 at academy meeting
Emilio Emini, David Ho, Mitchell Warren, Patricia Kahn and Jeffrey Laurence to speak on Wed, May 11
Therapeutic approaches to the treatment of HIV/AIDS over the last 25 years have led to the development of numerous drugs that are currently in use and that complement existing prevention programs. But the world is still awaiting the development of a safe and effective vaccine to prevent this devastating disease.
The NY Academy of Sciences, in collaboration with the AIDS Vaccine Advocacy Coalition (AVAC), will host an evening symposium, "HIV-1 Vaccines Update - Where Are We Now and Where Are We Headed?" featuring talks by key figures in the pursuit of the elusive goal of developing an HIV vaccine.
WHEN: May 11 at 5 p.m.
Q & A session and
reception to follow.
WHERE: New York Academy of Sciences, 2 East 63rd Street
SPEAKERS: Mitchell Warren, Executive Director, AIDS Vaccine Advocacy Coalition
David Ho, Director and Chief Executive Officer, Aaron Diamond AIDS Research Center (ADARC)
Emilio Emini, Senior Vice President - Vaccine Development, International AIDS Vaccine Initiative (IAVI)
Patricia Kahn, Freelance AIDS writer
Jeffrey Laurence, Cornell University Weill Medical Center, AmFAR
Mitchell Warren will make introductory remarks. Jeffrey Laurence will chair the meeting and lead a panel discussion following the presentations.
The NY Academy of Sciences is co-sponsoring this event along with AVAC, a non-profit, community- and consumer-based organization that uses public education, policy analysis, advocacy and community mobilization to accelerate the ethical development and global delivery of vaccine against HIV / AIDS.
For further information, visit the meetings/conferences section of the www.nyas.org web site.
Founded in 1817, the New York Academy of Sciences is a nonprofit membership organization dedicated to building communities and advancing science.